Litigation that resulted in multimillion-dollar verdicts around the country is poised to shut down in New Jersey without a single case tried to verdict and no known recoveries by the hundreds of women who claimed the hormones they took to alleviate symptoms of menopause instead caused cancer and other problems.

The New Jersey court system is preparing to close the book on the centralized litigation over hormone replacement therapy (HRT).

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]